Roche closer to breaking into lucrative SMA market with positive trial results
Positive trial results for an oral drug to treat spinal muscular atrophy (SMA) are bringing Roche one step closer to breaking into the high-cost treatment area.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals | Spinal Muscular Atrophy